[Cholestyramine interrupts the enterohepatic circulation of phenprocoumon: a new therapeutic possibility in the treatment of phenprocoumon overdose].
D015110:4-Hydroxycoumarins / Q000378:metabolism*; D001711:Biotransformation / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects; D002792:Cholestyramine Resin / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000378:metabolism*; D010644:Phenprocoumon / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011517:Prothrombin Time
D015110:4-Hydroxycoumarins; D002792:Cholestyramine Resin; D010644:Phenprocoumon
Colestyramin unterbricht den enterohepatischen Kreislauf von Phenprocoumon: Eine neue therapeutische Möglichkeit zur Behandlung der Phenprocoumonüberdosierung.